Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
ConditionMetastatic Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUNICANCER
About this trial
The Epidemiological Strategy and Medical Economic (ESME) Breast cancer Database is a multicenter real life database using a retrospective data collection process across 18 French comprehensive cancer centers (FCCC) spread over 20 sites. This database compiles data from patient's electronic medical records (EMR).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years old patient
Patient receiving chemotherapy, targeted therapy, immunotherapy, radiation therapy and hormonotherapy in a French Comprehensive Cancer Center.
Disqualifiers
None
Trial population
All consecutive patients treated for a metastatic breast cancer in a French Comprehensive Cancer Center over the selection period.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Describe the evolution of therapeutic care
Patient characteristics, tumor characteristics and treatment patterns
Time frame
baselineSecondary outcomes
1
Describe the impact of therapeutic strategies on survival criteria
Overall survival
Time frame
From date of diagnosis or first treatment until the date of date of death from any cause. Follow up until 2023.2
Describe the impact of therapeutic strategies on survival criteria
Progression free survival
Time frame
From date of diagnosis or first treatment until the date of first documented progression or date of death from any cause. Follow up until 2023.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
UNICANCER
Lead sponsor
Roche Pharma AG
Collaborator
Pierre Fabre Laboratories
Collaborator
Pfizer
Collaborator
AstraZeneca
Collaborator
Merck Sharp & Dohme LLC
Collaborator
Eisai Inc.
Collaborator
Daiichi Sankyo
Collaborator
Eli Lilly and Company
Collaborator
Gilead Sciences
Collaborator
Seagen Inc.
Collaborator
Source ClinicalTrials.gov